IPOX is pleased to announce that its flagship IPOX U.S. Index (ETF Ticker: FPX) reached a new all time high, surpassing the performance of all other benchmarks.

Based on the patented IPOX Indexes methodology, the IPOX-100 U.S. Index (BBG: IPXO and IPXUOTR) captures the performance of the top 100 U.S. domiciled IPOs and spin-offs offered over a four-year rotational cycle, providing ideal exposure to the unique effects of the “going public” event on large and mid-cap U.S. domiciled companies.

Calculated by leading index provider Standard & Poor’s, the IPOX-100 U.S. (IPXO) has gained +123.95% versus +25.01% for the S&P 500 Index (SPX) since its live inception on August 8th, 2004. The index currently pools USD 650bn of total U.S. market capitalization and USD 5.9 bn of average daily equity turnover on NASDAQ and NSYE. The average index constituent has a market cap of USD 6.4bn (median: USD 2.7b).